Cargando…
Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis
Vulvovaginal candidiasis is the most prevalent vaginal infection worldwide and Candida albicans is its major agent. Vulvovaginal candidiasis is characterized by disruption of the vaginal microbiota composition, as happens following large spectrum antibiotic usage. Recent studies support the effectiv...
Autores principales: | Pericolini, Eva, Gabrielli, Elena, Ballet, Nathalie, Sabbatini, Samuele, Roselletti, Elena, Cayzeele Decherf, Amélie, Pélerin, Fanny, Luciano, Eugenio, Perito, Stefano, Jüsten, Peter, Vecchiarelli, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963212/ https://www.ncbi.nlm.nih.gov/pubmed/27435998 http://dx.doi.org/10.1080/21505594.2016.1213937 |
Ejemplares similares
-
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019) -
Saccharomyces cerevisiae–based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis
por: Sabbatini, Samuele, et al.
Publicado: (2018) -
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis
por: Sabbatini, Samuele, et al.
Publicado: (2020) -
Chronic Vaginal Candidiasis Is Achievable in Outbred CD-1 Mice
por: Gabrielli, Elena, et al.
Publicado: (2017) -
Saccharomyces cerevisiae-Based Probiotics as Novel Antimicrobial Agents to Prevent and Treat Vaginal Infections
por: Gaziano, Roberta, et al.
Publicado: (2020)